Table 1 Prevalence and mean (SD) of sociodemographic, cardiometabolic, and comorbidity related variables in the study population
T1: N = 853 | T2: N = 954 | T1 & T2: N = 791 | |
|---|---|---|---|
Sociodemographic | |||
Women (%) | 47.9 | 49.9 | 48.2 |
Age (years) (mean (SD)) | 69.1 (7.6) | 69.3 (7.8) | 69.3 (7.6) |
Socio-Economic Status (%) | |||
Low | 32 | 34 | 33 |
Middle | 34 | 34 | 33 |
High | 34 | 32 | 34 |
Lifestyle | |||
Current smokers (%) | 6.7 | 6.5 | 7 |
Drinking alcohol (%) | 71 | 69 | 70 |
Adherence to Dutch healthy exercise norm (NNGB) (%) | 66 | 64 | 66 |
Cardiometabolic factors | |||
Waist circumference (cm) (mean (SD)) | 96.0 (11.9) | 96.3 (12.0) | 96.0 (12.0) |
BMI (kg/m2) (mean (SD)) | 26.4 (4.1) | 26.6 (4.2) | 26.4 (4.1) |
Systolic blood pressure (mmHg) (mean (SD)) | 133 (17) | 132 (17) | 133 (17) |
Total cholesterol (mmol/L) (mean (SD)) | 5.3 (1.0) | 5.3 (1.0) | 5.3 (1.0) |
HDL cholesterol (mmol/L) (mean (SD)) | 1.5 (0.4) | 1.5 (0.4) | 1.5 (0.4) |
Creatinine (mmol/L) (mean (SD)) | 83.1 (16.4) | 82.7 (16.6) | 83.0 (16.5) |
Glucose (mmol/L) (mean (SD)) | 5.8 (1.6) | 5.8 (1.6) | 5.8 (1.6) |
GlycA (mmol/L) (mean (SD)) | 0.9 (0.1) | 0.9 (0.1) | 0.9 (0.1) |
CRP (mmol/L) (mean (SD)) | 2.0 (4.2) | 2.2 (4.3) | 2.1 (4.3) |
Comorbidity related variables | |||
Frailty index (median (IQR)) | 0.07 (0.03–0.11) | 0.08 (0.03–0.11) | 0.07 (0.03–0.11) |
FEV1 max (mean (SD)) | 3.1 (0.8) | 3.0 (0.8) | 3.1 (0.8) |
FVC max (mean (SD)) | 4.2 (1.0) | 4.1 (1.0) | 4.2 (1.1) |
FEV1/FVC ratio (mean (SD)) | 0.7 (0.1) | 0.7 (0.1) | 0.7 (0.1) |
eGFR (mean (SD)) | 0.9 (0.2) | 0.9 (0.2) | 0.9 (0.2) |
Having > = 1 comorbidity (%) | 62 | 60 | 61 |